Skip to content
Company Analysis

Utah Medical Products, Inc. UTMD

A comprehensive view of key metrics, scores, and financial health for Utah Medical Products, Inc.

Overview of Utah Medical Products, Inc.

UTMD NMS
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Micro Cap
Utah Medical Products, Inc. (UTMD), is a Micro Cap company, in the Medical Instruments & Supplies industry, last closed at $69.16, about 67.3% overvalued vs fair value, +11.0% 1Y return, placing in the top 10% of its sector.
Metrics P/E 16.1× Rev Growth -5.8% ROE 9.5% Gross Margin 57.1% Div Yield 2.22%
USD 69.16
-2.73%
(Delayed)
• Vol 90d: 35.3%
52-Week Range
Market Cap
$217.72M
Enterprise Value
$130.39M
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Good
Health
Fair
Efficiency
Good
Valuation
Good
Growth
Weak
Profitability
Good
Health
Fair
Efficiency
Good
Valuation
Good
Completeness: 100%
Confidence: 59%
Updated: Sep 12
Top Beats

Quick Facts

Website https://www.utahmed.com
HQ Midvale, UT
Fiscal year Dec 31

Next Events

Dividend Oct 5 Ex-div: Sep 17
Earnings Oct 22 Estimated

Fair Value Snapshot

Bear Base Bull
$20
$23
$25
Current: $69.16 -67% vs base

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$38.5M
-5.8%%
Gross Profit
$22.0M
-8.9%%
Operating Income (GAAP)
$11.4M
-16.1%%
EBITDA
$14.4M
-12.3%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
57.1%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$12.3M
86.2% of Free Cash Flow

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
1
Active Leaks
0/1
Improving
0
High Impact
0
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Utah Medical Products, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
70
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Superior Capital Returns Capital return quality is top-tier (score 0.75). High ROIC indicates the business is reinvesting at attractive rates.
  • Strong FCF Generation FCF margin quality is top-tier vs peers (score 1.00). High FCF conversion confirms strong earnings quality.

Key risks

  • Declining FCF Margin FCF trend score is negative (score 0.25). Declining FCF margin warrants scrutiny of capital allocation discipline.
  • Operating Margin Compression Operating margin trend is negative (score 0.24). Sustained compression would reduce the commercial moat.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
64
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 100% Coverage
Trade-Off Triangle Visualization A ternary plot showing UTMD's balance between Growth (13.6%), Profitability (41.4%), and Safety (45.0%). Growth 14% Safety 45% Profitability 41%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

27th percentile vs peers
27
Key Signals
Rev Growth YoY -5.8% 24p EPS Growth YoY -12.0% 26p TSR -6.9% 46p EPS CAGR 3Y -8.3% 27p Revenue CAGR 3Y -9.7% 16p
Strengths
  • FCF Margin in top 20% of peers (37.2%, 99th percentile)
  • Operating Margin in top 20% of peers (29.6%, 97th percentile)
  • Interest Coverage (EBITDA) in top 20% of peers (30.92, 91th percentile)
Risks
  • Growth below peer median (percentile: 27)

Profitability

82th percentile vs peers
83
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

90th percentile vs peers
90
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Utah Medical Products, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$22.63
- - -
-67.3% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000